Literature DB >> 23199499

Immunology of hepatitis C virus infections.

Michelle Spaan1, Harry L A Janssen, Andre Boonstra.   

Abstract

The immune response in patients chronically infected with HCV plays a unique role during the infection because of its potential to contribute not only to viral clearance and, in some cases, protective immunity, but also to liver injury. A detailed understanding of the immunological mechanisms involved in persistence to HCV is essential to fully appreciate the complexity of the disease. In recent years, enormous progress has been made to characterize the dysfunctional natural killer cells and T cells during the chronic phase of infection. This information is important to further optimize treatment strategies based on the strengthening antiviral and immunomodulatory activities in patients chronically infected with HCV.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23199499     DOI: 10.1016/j.bpg.2012.09.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  10 in total

Review 1.  NK cells in immunotolerant organs.

Authors:  Haoyu Sun; Cheng Sun; Zhigang Tian; Weihua Xiao
Journal:  Cell Mol Immunol       Date:  2013-04-08       Impact factor: 11.530

2.  Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.

Authors:  Mark H Kuniholm; Xianhong Xie; Kathryn Anastos; Robert C Kaplan; Xiaonan Xue; Andrea Kovacs; Marion G Peters; Eric C Seaberg; Audrey L French; Mary A Young; Michael Augenbraun; Jeffrey A Martinson; Kristin A Bush; Alan L Landay; Howard D Strickler
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

Review 3.  Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.

Authors:  Kate S O'Connor; Jacob George; David Booth; Golo Ahlenstiel
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

4.  CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.

Authors:  Melissa A Sheiko; Lucy Golden-Mason; Silvia Giugliano; Christine Waasdorp Hurtado; Cara L Mack; Michael R Narkewicz; Hugo R Rosen
Journal:  J Pediatr       Date:  2015-12-30       Impact factor: 4.406

5.  Treatment of chronic hepatitis C in a Canadian Aboriginal population: results from the PRAIRIE study.

Authors:  Gerald Y Minuk; Meaghan O'Brien; Kim Hawkins; Didi Emokpare; James McHattie; Paul Harris; Lawrence Worobetz; Karen Doucette; Kelly Kaita; Stephen Wong; Gilles Pinette; Julia Uhanova
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

6.  Persistent Replication of HIV, Hepatitis C Virus (HCV), and HBV Results in Distinct Gene Expression Profiles by Human NK Cells.

Authors:  Lauke L Boeijen; Jun Hou; Rik A de Groen; Annelies Verbon; André Boonstra
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

7.  Follicular helper T cell and memory B cell immunity in CHC patients.

Authors:  Yong Liu; Huifan Ji; Pingwei Zhao; Hongqing Yan; Yanjun Cai; Lei Yu; Xiaoli Hu; Xiguang Sun; Yanfang Jiang
Journal:  J Mol Med (Berl)       Date:  2019-01-21       Impact factor: 4.599

Review 8.  Methodologies for the Analysis of HCV-Specific CD4(+) T Cells.

Authors:  Megha U Lokhande; Robert Thimme; Paul Klenerman; Nasser Semmo
Journal:  Front Immunol       Date:  2015-02-25       Impact factor: 7.561

Review 9.  Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?

Authors:  Sayed F Abdelwahab
Journal:  Infect Agent Cancer       Date:  2016-05-16       Impact factor: 2.965

10.  The relationship between human leukocyte antigen-DP/DQ gene polymorphisms and the outcomes of HCV infection in a Chinese population.

Authors:  Peng Huang; Haozhi Fan; Ting Tian; Peiwen Liao; Jun Li; Rongbin Yu; Xueshan Xia; Yue Feng; Jie Wang; Yuan Liu; Yun Zhang; Ming Yue
Journal:  Virol J       Date:  2017-12-06       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.